Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes

被引：0
|
作者：
Marco Witkowski
Julian Friebel
Termeh Tabaraie
Sinah Grabitz
Andrea Dörner
Lena Taghipour
Kai Jakobs
Bernd Stratmann
Diethelm Tschoepe
Ulf Landmesser
Ursula Rauch
机构：
[1] Charité – Universitätsmedizin Berlin,Charité Centrum 11, Department of Cardiology
[2] Campus Benjamin Franklin,Herz und Diabeteszentrum NRW
[3] Ruhr Universität Bochum,undefined
来源：
Cardiovascular Drugs and Therapy | 2021年 / 35卷
关键词：
Metformin; diabetes mellitus; coagulation; tissue factor; vascular inflammation; thrombosis; microRNA; vascular complications; cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：809 / 813
页数：4
相关论文
共 50 条
  • [31] Rapid effect of repaglinide in combination with metformin in poorly controlled obese patients with type 2 diabetes mellitus
    Kurashvili, R.
    Asatiani, N.
    Nishnianidze, M.
    Dundua, M.
    Shelestova, E.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S163 - S163
  • [32] Factors associated with diet barriers in patients with poorly controlled type 2 diabetes
    Cheng, Li
    Leung, Doris Yin-Ping
    Sit, Janet Wing-hung
    Li, Xiao-mei
    Wu, Yu-ning
    Yang, Miao-yan
    Gao, Cui-xia
    Hui, Rong
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 37 - 44
  • [33] Increased procoagulant activity of tissue factor-expressing microvesicles in patients with liver cirrhosis
    Protopapas, Adonis
    Takardaki, Anna
    Protopapa, Nefeli
    Papagiouvanni, Ioanna
    Protopapas, Andreas
    Skoura, Lemonia
    Savopoulos, Christos
    Goulis, Ioannis
    JOURNAL OF HEPATOLOGY, 2024, 80 : S196 - S197
  • [34] Microvesicle Tissue Factor Procoagulant Activity Is Elevated and Correlated With Disease Severity in Patients With Cirrhosis
    Protopapas, Adonis A.
    Takardaki, Anna
    Protopapa, Nefeli
    Papagiouvanni, Ioanna
    Protopapas, Andreas N.
    Skoura, Lemonia
    Savopoulos, Christos
    Goulis, Ioannis
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [35] Cellular origin and procoagulant activity of tissue factor-exposing microparticles in cancer patients
    Kleinjan, A.
    Berckmans, R. J.
    Boing, A. N.
    Sturk, A.
    Buller, H. R.
    Kamphuisen, P. W.
    Nieuwland, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 648 - 648
  • [36] Cellular origin and procoagulant activity of tissue factor-exposing microparticles in cancer patients
    Kleinjan, A.
    Berckmans, R. J.
    Boing, A. N.
    Sturk, A.
    Bueller, H. R.
    Kamphuisen, P. W.
    Nieuwland, R.
    THROMBOSIS RESEARCH, 2012, 129 : S161 - S161
  • [37] Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease
    Key, NS
    Slungaard, A
    Dandelet, L
    Nelson, SC
    Moertel, C
    Styles, LA
    Kuypers, FA
    Bach, RR
    BLOOD, 1998, 91 (11) : 4216 - 4223
  • [38] Elevated whole blood tissue factor procoagulant activity in diabetes mellitus.: Vitamin E inhibits glucose induced tissue factor activity in vitro.
    Abdel-Hafiz, E
    Vaidyula, VR
    Bagga, S
    London, FS
    Boden, G
    Rao, AK
    BLOOD, 2002, 100 (11) : 496A - 496A
  • [39] Metformin epigenetically regulates tissue factor expression in diabetes
    Witkowski, M.
    Friebel, J.
    Tabaraie, T.
    Weithauser, A.
    Steffens, D.
    Stratmann, B.
    Tschoepe, D.
    Doerner, A.
    Kasner, M.
    Landmesser, U.
    Rauch, U.
    EUROPEAN HEART JOURNAL, 2017, 38 : 233 - 233
  • [40] Activated EPCs produce tissue factor and have procoagulant activity
    Di Stefano, R.
    Celi, A.
    Santoni, T.
    Barsotti, M. C.
    Armani, C.
    Balbarini, A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 688 - 688
12345